Publishing research using ab120343? Please let us know so that we can cite the reference in this datasheet.
ab120343 has been referenced in 3 publications.
Bancila M et al.Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats.Fundam Clin Pharmacol 25:469-78 (2011).
Major TC et al.The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.J Pharmacol Exp Ther 325:723-31 (2008).
Clozel JP et al.Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.J Hypertens Suppl 15:S17-25 (1997).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"
Get resources and offers direct to your inboxSign up